Literature DB >> 2903459

Multiple forms of beta-amyloid peptide precursor RNAs in a single cell type.

R J Donnelly1, C G Rasool, R Bartus, S Vitek, A J Blume, M Vitek.   

Abstract

The longest open reading frames (ORFs) of three different cDNAs ([10, 12, 18, 26], and this report) contain the exact 42 amino acid (aa) sequence of the beta-amyloid peptide (BAP) which is selectively deposited in Alzheimer's diseased (AD) brains. Each of the three cDNAs for the putative amyloid peptide precursor (APP) has been cloned from a different cell type. Using an HL 60 library, we have cloned two of these three APP cDNAs from a single cell type. The sequences of the HL 60 cDNAs are identical to the APP 751 and to the APP 770 forms of APP cDNAs. Northern blots show that oligonucleotide probes drawn from unique regions of the APP 751 and APP 770 cDNAs both hybridize to 4.0 Kilobase (Kb) and to 1.6 Kb APP RNAs from HL 60 cells. In human adult brain, an oligonucleotide probe drawn from the unique region of the APP 751 cDNA hybridizes to a 3.5 Kb APP RNA. However, a DNA probe drawn from the BAP region, which is common to the 695, 751, and 770 forms of APP cDNAs, hybridizes to 3.5, 3.2 and 1.6 Kb APP RNAs. Taken together, these results show that at least two forms of APP RNAs can exist within a single cell type and that the diversity of possible APP RNAs and complexity of their expression may have been underestimated. Thus, in addition to identifying the cells which produce BAP, a new challenge consists of determining which form of forms of APP RNAs and hence APP proteins are associated with BAP deposition in AD and Down syndrome (DS).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903459     DOI: 10.1016/s0197-4580(88)80078-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Interleukin-1 stimulates the beta-amyloid precursor protein promoter.

Authors:  R J Donnelly; A J Friedhoff; B Beer; A J Blume; M P Vitek
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

Review 2.  The molecular pathology of amyloid deposition in Alzheimer's disease.

Authors:  R N Martins; P J Robinson; J O Chleboun; K Beyreuther; C L Masters
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Authors:  D Goldgaber; H W Harris; T Hla; T Maciag; R J Donnelly; J S Jacobsen; M P Vitek; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Authors:  M P Vitek; K Bhattacharya; J M Glendening; E Stopa; H Vlassara; R Bucala; K Manogue; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 5.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

Review 6.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

7.  Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice.

Authors:  D O Wirak; R Bayney; C A Kundel; A Lee; G A Scangos; B D Trapp; A J Unterbeck
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.